BioPharma Dive ١٢ مارس ٢٠٢٦ Lilly warns GLP-1 knockoffs may be ‘dangerous,’ escalating war with compounders
BioPharma Dive ١١ مارس ٢٠٢٦ FDA clears repurposed GSK drug for ultra-rare brain disease instead of autism
BioPharma Dive ١٠ مارس ٢٠٢٦ Xenon hits a ‘home run’ in epilepsy; FDA restarts review of Duchenne cell therapy
BioPharma Dive ٩ مارس ٢٠٢٦ Bristol Myers claims success in study of another next-gen blood cancer drug
BioPharma Dive ٩ مارس ٢٠٢٦ Rethinking the box: Why circular cold chain packaging is becoming a cost strategy in healthcare
BioPharma Dive ٩ مارس ٢٠٢٦ Navigating the PPQ process: Proven strategies to safeguard quality for cell and gene therapies